Back to top

Sino Biopharmaceutical Reports Breakthrough in GVHD Treatment with Rovadicitinib

The latest announcement is out from Sino Biopharmaceutical ( ($HK:1177) ). Sino Biopharmaceutical Limited announced promising results from preclini...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sino Biopharmaceutical (SBMFF)